Impact Of A Pharmacological Cardioversion With Vernakalant On The Management Cost Of Recent Atrial Fibrillation In Belgium
Abstract
Authors
M. Lamotte L. Gerlier K. Caekelbergh K. Lalji J. Polifka E. Lee
M. Lamotte L. Gerlier K. Caekelbergh K. Lalji J. Polifka E. Lee
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now